These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18191803)

  • 1. Increasing exposure to angiotensin-converting enzyme inhibitors in pregnancy.
    Bowen ME; Ray WA; Arbogast PG; Ding H; Cooper WO
    Am J Obstet Gynecol; 2008 Mar; 198(3):291.e1-5. PubMed ID: 18191803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of increased congenital malformations after first trimester exposures to angiotensin-converting enzyme inhibitors.
    Cooper WO
    J Cardiovasc Nurs; 2008; 23(1):20-4. PubMed ID: 18158502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors.
    Piper JM; Ray WA; Rosa FW
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):429-32. PubMed ID: 1495700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major congenital malformations after first-trimester exposure to ACE inhibitors.
    Cooper WO; Hernandez-Diaz S; Arbogast PG; Dudley JA; Dyer S; Gideon PS; Hall K; Ray WA
    N Engl J Med; 2006 Jun; 354(23):2443-51. PubMed ID: 16760444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity.
    Schaefer C
    Birth Defects Res A Clin Mol Teratol; 2003 Aug; 67(8):591-4. PubMed ID: 14632309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors.
    Morimoto T; Gandhi TK; Fiskio JM; Seger AC; So JW; Cook EF; Fukui T; Bates DW
    J Eval Clin Pract; 2004 Nov; 10(4):499-509. PubMed ID: 15482412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of angiotensin converting enzyme (ACE) inhibitors during pregnancy clearly increases the risk of congenital malformations].
    de Leeuw PW
    Ned Tijdschr Geneeskd; 2006 Jul; 150(29):1605-7. PubMed ID: 16901062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible oligohydramnios in a pregnancy with angiotensin-converting enzyme inhibitor exposure.
    Chisholm CA; Chescheir NC; Kennedy M
    Am J Perinatol; 1997 Oct; 14(9):511-3. PubMed ID: 9394157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient use of cardiovascular drugs during pregnancy.
    Andrade SE; Raebel MA; Brown J; Lane K; Livingston J; Boudreau D; Rolnick SJ; Roblin D; Smith DH; Dal Pan GJ; Scott PE; Platt R
    Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):240-7. PubMed ID: 18200619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
    Austin PC; Tu JV; Ko DT; Alter DA
    CMAJ; 2008 Oct; 179(9):901-8. PubMed ID: 18936455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment.
    Tabacova S; Little R; Tsong Y; Vega A; Kimmel CA
    Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):633-46. PubMed ID: 14762979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of angiotensin-converting enzyme inhibitor therapy in diastolic heart failure.
    Tribouilloy C; Rusinaru D; Leborgne L; Peltier M; Massy Z; Slama M
    Am J Cardiol; 2008 Mar; 101(5):639-44. PubMed ID: 18308013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative Angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting.
    Benedetto U; Sciarretta S; Roscitano A; Fiorani B; Refice S; Angeloni E; Sinatra R
    Ann Thorac Surg; 2008 Oct; 86(4):1160-5. PubMed ID: 18805152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcomes following hospitalisation for a fall in Washington State from 1987 to 2004.
    Schiff MA
    BJOG; 2008 Dec; 115(13):1648-54. PubMed ID: 18947341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy--United States, Canada, and Israel, 1987-1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Mar; 46(11):240-2. PubMed ID: 9082178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of prescription medications with a potential for fetal harm among pregnant women.
    Andrade SE; Raebel MA; Morse AN; Davis RL; Chan KA; Finkelstein JA; Fortman KK; McPhillips H; Roblin D; Smith DH; Yood MU; Platt R; H Gurwitz J
    Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):546-54. PubMed ID: 16586470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands.
    Bakker MK; Jentink J; Vroom F; Van Den Berg PB; De Walle HE; De Jong-Van Den Berg LT
    BJOG; 2006 May; 113(5):559-68. PubMed ID: 16637899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged exposure to angiotensin-converting enzyme inhibitors during pregnancy. Fetal toxicity could be reversible.
    Shrim A; Berger H; Kingdom J; Hamoudi A; Shah PS; Koren G
    Can Fam Physician; 2005 Oct; 51(10):1335-7. PubMed ID: 16250418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
    Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
    J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.